TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pharmaxim AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
194,440
|
174,499
|
153,294 |
| Financial expenses |
991
|
915
|
419 |
| Earnings before taxes |
6,337
|
11,659
|
9,329 |
| EBITDA |
7,732
|
12,974
|
9,854 |
| Total assets |
102,567
|
90,797
|
91,626 |
| Current assets |
71,887
|
59,932
|
63,543 |
| Current liabilities |
41,141
|
28,320
|
47,644 |
| Equity capital |
45,896
|
44,873
|
41,131 |
| - share capital |
1,150
|
1,150
|
1,150 |
| Employees (average) |
16
|
14
|
15 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
44.7%
|
49.4%
|
44.9% |
| Turnover per employee |
12,152
|
12,464
|
10,220 |
| Profit as a percentage of turnover |
3.3%
|
6.7%
|
6.1% |
| Return on assets (ROA) |
7.1%
|
13.8%
|
10.6% |
| Current ratio |
174.7%
|
211.6%
|
133.4% |
| Return on equity (ROE) |
13.8%
|
26.0%
|
22.7% |
| Change turnover |
19,941
|
21,205
|
-29,271 |
| Change turnover % |
11%
|
14%
|
-16% |
| Chg. No. of employees |
2
|
-1
|
-1 |
| Chg. No. of employees % |
14%
|
-7%
|
-6% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.